Literature DB >> 24285743

Plasma protein biomarkers of the geriatric syndrome of frailty.

Kayla Darvin1, Amanda Randolph, Symphony Ovalles, Dipti Halade, Leah Breeding, Arlan Richardson, Sara E Espinoza.   

Abstract

Frailty is a geriatric syndrome associated with physical decline with aging. Using a proteomics-based screening method to screen plasma for potential biomarkers, we previously found inflammatory glycoproteins to be increased with frailty. The purpose of this study was to confirm if plasma levels of these glycoproteins, as well as of interleukin-6, are increased with frailty in a larger sample (n = 65) of community-dwelling older adults. Plasma levels of transferrin, fibrinogen, haptoglobin, and interleukin-6 were determined with enzyme-linked immunosorbent assay. Differences in protein concentrations by frailty status were determined using analysis of variance. Higher levels of transferrin (p < .001), fibrinogen (p < .0001), and interleukin-6 (p = .0035) were associated with frailty status (nonfrail, prefrail, or frail) and frailty score (0-5) in this sample even after adjustment for age and sex. Haptoglobin did not differ by frailty status (p = .05). Our findings largely confirmed the findings of our nontargeted approach that inflammatory glycoproteins are increased with frailty. Future studies should include larger examinations of these associations and consider the potential usefulness of these glycoproteins as biomarkers for frailty.

Entities:  

Keywords:  Biomarkers.; Frailty

Mesh:

Substances:

Year:  2013        PMID: 24285743      PMCID: PMC4038243          DOI: 10.1093/gerona/glt183

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  27 in total

1.  Guidelines for improving the care of the older person with diabetes mellitus.

Authors:  Arlene F Brown; Carol M Mangione; Debra Saliba; Catherine A Sarkisian
Journal:  J Am Geriatr Soc       Date:  2003-05       Impact factor: 5.562

2.  Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

Authors:  Jeremy Walston; Mary Ann McBurnie; Anne Newman; Russell P Tracy; Willem J Kop; Calvin H Hirsch; John Gottdiener; Linda P Fried
Journal:  Arch Intern Med       Date:  2002-11-11

3.  Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels.

Authors:  Luigi Ferrucci; Brenda W J H Penninx; Stefano Volpato; Tamara B Harris; Karen Bandeen-Roche; Jennifer Balfour; Suzanne G Leveille; Linda P Fried; Jack M Guralnik Md
Journal:  J Am Geriatr Soc       Date:  2002-12       Impact factor: 5.562

4.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

5.  Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.

Authors:  T B Harris; L Ferrucci; R P Tracy; M C Corti; S Wacholder; W H Ettinger; H Heimovitz; H J Cohen; R Wallace
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

Review 6.  Biological interactions of aging and anemia: a focus on cytokines.

Authors:  William B Ershler
Journal:  J Am Geriatr Soc       Date:  2003-03       Impact factor: 5.562

7.  Impact of anemia and cardiovascular disease on frailty status of community-dwelling older women: the Women's Health and Aging Studies I and II.

Authors:  Paulo H M Chaves; Richard D Semba; Sean X Leng; Richard C Woodman; Luigi Ferrucci; Jack M Guralnik; Linda P Fried
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-06       Impact factor: 6.053

8.  Serum levels of insulin-like growth factor-I (IGF-I) and dehydroepiandrosterone sulfate (DHEA-S), and their relationships with serum interleukin-6, in the geriatric syndrome of frailty.

Authors:  Sean X Leng; Anne R Cappola; Ross E Andersen; Marc R Blackman; Kathleen Koenig; Michael Blair; Jeremy D Walston
Journal:  Aging Clin Exp Res       Date:  2004-04       Impact factor: 3.636

9.  Clinical Global Impression of Change in Physical Frailty: development of a measure based on clinical judgment.

Authors:  Stephanie Studenski; Risa P Hayes; Ruth Q Leibowitz; Rita Bode; Laurie Lavery; Jeremy Walston; Pamela Duncan; Subashan Perera
Journal:  J Am Geriatr Soc       Date:  2004-09       Impact factor: 5.562

Review 10.  Frailty in elderly people.

Authors:  Andrew Clegg; John Young; Steve Iliffe; Marcel Olde Rikkert; Kenneth Rockwood
Journal:  Lancet       Date:  2013-02-08       Impact factor: 79.321

View more
  28 in total

1.  Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.

Authors:  David Frescas; Christelle M Roux; Semra Aygun-Sunar; Anatoli S Gleiberman; Peter Krasnov; Oleg V Kurnasov; Evguenia Strom; Lauren P Virtuoso; Michelle Wrobel; Andrei L Osterman; Marina P Antoch; Vadim Mett; Olga B Chernova; Andrei V Gudkov
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-13       Impact factor: 11.205

Review 2.  Premature Physiologic Aging as a Paradigm for Understanding Increased Risk of Adverse Health Across the Lifespan of Survivors of Childhood Cancer.

Authors:  Kirsten K Ness; James L Kirkland; Maria Monica Gramatges; Zhaoming Wang; Mondira Kundu; Kelly McCastlain; Xiujie Li-Harms; Jinghui Zhang; Tamar Tchkonia; Saskia Martine Francesca Pluijm; Gregory T Armstrong
Journal:  J Clin Oncol       Date:  2018-06-06       Impact factor: 44.544

3.  The Independent Role of Inflammation in Physical Frailty among Older Adults with Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.

Authors:  L Tay; W S Lim; M Chan; R J Ye; M S Chong
Journal:  J Nutr Health Aging       Date:  2016-03       Impact factor: 4.075

4.  Inflammatory Markers and Frailty in Long-Term Care Residents.

Authors:  Gabrielle A Langmann; Subashan Perera; Mary A Ferchak; David A Nace; Neil M Resnick; Susan L Greenspan
Journal:  J Am Geriatr Soc       Date:  2017-03-21       Impact factor: 5.562

5.  Impact of Longevity Interventions on a Validated Mouse Clinical Frailty Index.

Authors:  Alice E Kane; Sarah N Hilmer; Dawn Boyer; Kristan Gavin; Dawn Nines; Susan E Howlett; Rafael de Cabo; Sarah J Mitchell
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-02-22       Impact factor: 6.053

Review 6.  Frailty biomarkers in humans and rodents: Current approaches and future advances.

Authors:  Alice E Kane; David A Sinclair
Journal:  Mech Ageing Dev       Date:  2019-04-17       Impact factor: 5.432

Review 7.  Physiological Systems in Promoting Frailty.

Authors:  Laís R Perazza; Holly M Brown-Borg; LaDora V Thompson
Journal:  Compr Physiol       Date:  2022-04-26       Impact factor: 8.915

Review 8.  Frailty in Aging and the Search for the Optimal Biomarker: A Review.

Authors:  Magdalena Sepúlveda; Diego Arauna; Francisco García; Cecilia Albala; Iván Palomo; Eduardo Fuentes
Journal:  Biomedicines       Date:  2022-06-16

9.  Malnutrition and Laboratory Markers in Geriatric Patients. A Comparison of Neurologic-psychiatric, Internal and Trauma Surgical Diseases.

Authors:  F S Schreiber; I Becker; P Deckert; H Elsbernd; C Isensee
Journal:  J Nutr Health Aging       Date:  2016-04       Impact factor: 4.075

Review 10.  Association of inflammatory mediators with frailty status in older adults: results from a systematic review and meta-analysis.

Authors:  Diego Marcos-Pérez; María Sánchez-Flores; Stefania Proietti; Stefano Bonassi; Solange Costa; Joao Paulo Teixeira; Juan Fernández-Tajes; Eduardo Pásaro; Blanca Laffon; Vanessa Valdiglesias
Journal:  Geroscience       Date:  2020-08-15       Impact factor: 7.713

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.